CD79A and amyotrophic lateral sclerosis: A strong agreement (Kappa >0.7, LCL ≥0.5) is seen between IgA-and IgG-ALS responders/non-responders and IgA- and IgG-ASC and IgA serum antibody responders to IVP and IpaB-specific antigens.